Coya Therapeutics publishes study linking ALS biomarkers to survival

Go back to Coya Therapeutics publishes study linking ALS biomarkers to survival
(NASDAQ: COYA) Delayed: 5.26 --0 (-0%)
Previous Close $5.26    52 Week High
Open $5.33    52 Week Low
Day High $5.64    P/E N/A 
Day Low $4.99    EPS
Volume 392,165